The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.

<h4>Background</h4>The accurate assessment of liver fibrosis among hemodialysis patients with chronic hepatitis C (CHC) is important for both treatment and for follow up strategies. Applying the non-invasive methods in general population with viral hepatitis have been successful but the...

Full description

Bibliographic Details
Main Authors:	Jia-Jung Lee, Yu-Ju Wei, Ming-Yen Lin, Sheng-Wen Niu, Po-Yao Hsu, Jiun-Chi Huang, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Shang-Jyh Hwang, Chung-Feng Huang, Yi-Wen Chiu, Wan-Long Chuang, Ming-Lung Yu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0242601

Similar Items

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
by: Po-Yao Hsu, et al.
Published: (2021-01-01)

Association of relatives of hemodialysis patients with metabolic syndrome, albuminuria and Framingham Risk Score.
by: Jiun-Chi Huang, et al.
Published: (2014-01-01)

COVID-19 Vaccines in Patients with Maintenance Hemodialysis
by: Cheng-Chieh Yen, et al.
Published: (2021-08-01)

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
by: Ming-Yen Hsieh, et al.
Published: (2012-02-01)

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
by: Ming-Lun Yeh, et al.
Published: (2017-01-01)

Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma
by: Ming-Lun Yeh, et al.
Published: (2015-02-01)

Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection
by: Chung-Feng Huang, et al.
Published: (2015-05-01)

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients
by: Ching-I Huang, et al.
Published: (2017-08-01)

Association between Age and Changes in Heart Rate Variability after Hemodialysis in Patients with Diabetes
by: Sheng-Wen Niu, et al.
Published: (2018-02-01)

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
by: Tsai Jung-Fa, et al.
Published: (2005-04-01)

Qualitative Application of COBAS AMPLICOR HCV Test Version 2.0 Assays in Patients with Chronic Hepatitis C Virus Infection and Comparison of Clinical Performance with Version 1.0
by: Ming-Yen Hsieh, et al.
Published: (2007-07-01)

Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community-based Study
by: Jeng-Fu Yang, et al.
Published: (2010-09-01)

Association of hyperuricemia with disease severity in chronic hepatitis C patients.
by: Tyng-Yuan Jang, et al.
Published: (2018-01-01)

Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study
by: Ming-Lun Yeh, et al.
Published: (2016-11-01)

Association between gallbladder stones and chronic hepatitis C: Ultrasonographic survey in a hepatitis C and B hyperendemic township in Taiwan
by: Chia-Yen Dai, et al.
Published: (2013-08-01)

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
by: Ming-Lun Yeh, et al.
Published: (2015-01-01)

Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients.
by: Chung-Feng Huang, et al.
Published: (2013-01-01)

Changes in acoustic cardiographic parameters before and after hemodialysis are associated with overall and cardiovascular mortality in hemodialysis patients
by: Tung-Ling Chung, et al.
Published: (2021-01-01)

Cure or curd: Modification of lipid profiles and cardio‐cerebrovascular events after hepatitis C virus eradication
by: Chung‐Feng Huang, et al.
Published: (2020-11-01)

Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinoma
by: Zu‐Yau Lin, et al.
Published: (2021-07-01)

The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C
by: Po-Cheng Liang, et al.
Published: (2018-01-01)

Association between Reduced Serum Zinc and Diastolic Dysfunction in Maintenance Hemodialysis Patients
by: Jiun-Chi Huang, et al.
Published: (2021-06-01)

Progression of Aortic Arch Calcification Is Associated with Overall and Cardiovascular Mortality in Hemodialysis
by: Wei-Shiuan Chung, et al.
Published: (2020-01-01)

Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment
by: Zu‐Yau Lin, et al.
Published: (2020-09-01)

Primary culture of aspiration residual specimens improves the diagnostic accuracy between hepatocellular carcinoma and benign nodules
by: Zu‐Yau Lin, et al.
Published: (2020-06-01)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
by: Ming‐Lun Yeh, et al.
Published: (2021-02-01)

The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment
by: Ming‐Lun Yeh, et al.
Published: (2019-10-01)

Comparison of Clinical Application of the Abbott HBV PCR Kit and the Versant HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese Patients
by: Jeng-Fu Yang, et al.
Published: (2009-08-01)

Real‐world effectiveness of direct‐acting antiviral agents for chronic hepatitis C patients with genotype‐2 infection after completed treatment
by: Tzu‐Sheng Cheng, et al.
Published: (2021-04-01)

The performance of acoustic radiation force impulse imaging in predicting liver fibrosis in chronic liver diseases
by: Yi-Hung Lin, et al.
Published: (2016-07-01)

Investigation of Acoustic Cardiographic Parameters before and after Hemodialysis
by: Hui-Ju Tsai, et al.
Published: (2019-01-01)

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan
by: Pei-Chien Tsai, et al.
Published: (2017-01-01)

Alström Syndrome with Acute Pancreatitis: A Case Report
by: Wen-Chih Wu, et al.
Published: (2003-07-01)

Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients.
by: Ming-Lun Yeh, et al.
Published: (2019-01-01)

Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for treatment of recurrent chronic hepatitis C genotype 1 infection after liver transplantation: Real-world experience
by: Ming-Lung Yu, et al.
Published: (2018-06-01)

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection
by: Ta-Ya Lin, et al.
Published: (2017-06-01)

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients.
by: Jee-Fu Huang, et al.
Published: (2015-01-01)

Hepatocellular Carcinoma Associated With Liver Abscess
by: Ching-I Huang, et al.
Published: (2009-10-01)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.
by: Chuan-Pin Lin, et al.
Published: (2021-01-01)

The association of echocardiographic parameters on renal outcomes in chronic kidney disease
by: Tzu-Heng Huang, et al.
Published: (2021-01-01)